Tariffs are affecting many industries in 2025, and pharmaceuticals are not being spared. Although new U.S. tariffs on Chinese imports were briefly enacted this year, they were quickly placed on hold. This pause has not eliminated uncertainty. Instead, it has added to the broader sense of economic hesitation, especially in industries like pharmaceuticals that depend […]
In the increasingly complex world of global labeling, tracking changes across labeling content is more than a best practice—it’s a regulatory necessity. Health authorities around the globe are demanding more detailed accountability, documentation, and traceability of every change made throughout the product lifecycle. Staying compliant is a major challenge for many companies, especially those with […]
In the life sciences world, there’s been no shortage of excitement around the potential of FHIR (Fast Healthcare Interoperability Resources). As a data standard, FHIR promises to modernize how we share, update, and use health and regulatory data across systems, borders, and teams. It fosters global interoperability and reliance, reducing the amount of work and […]
Pharmaceutical companies create vast amounts of information across multiple channels, formats, and audiences. Managing this complexity while maintaining quality, consistency, and compliance can feel overwhelming. By leveraging a component-based structured content platform, organizations can turn this challenge into an opportunity for greater efficiency and control. A component-based structured content platform breaks down content into reusable, […]
Electronic Product Information (ePI) with FHIR standards is a fast-growing regulatory requirement, prompting pharmaceutical companies to evaluate how best to manage this transition. Companies are facing increasing operational and financial decisions to remain compliant and need to determine if they will leverage an outsource vendor, implement a solution in house, or both. For many, implementing […]
As 2025 approaches, the pharmaceutical industry faces increasing pressure to streamline operations and ensure regulatory compliance while adapting to the growing complexities of global drug labeling requirements. Integrating AI into your existing drug labeling processes is an innovative way to address these challenges head-on. The coming year promises both challenges and opportunities for the pharmaceutical […]
In the rapidly evolving landscape of pharmaceutical documentation, the drug labeling workflow is undergoing its most significant transformation in history. The shift from traditional, cumbersome methods of document creation and approval, to streamlined, AI-driven processes is paving the way for a future where drug labeling is more efficient, precise, and adaptable than ever before. This […]
Navigating the intricacies of clinical labeling can be intimidating. With regulatory agencies keeping a watchful eye on everything you do, finding ways to improve the clinical labeling process while maintaining regulatory compliance may seem impossible. However, incorporating automation into this process is simpler than you might think, with advantages that extend far beyond compliance. Automation […]
An effective AI-based labeling system can significantly reduce errors, save time, and adapt to evolving business needs – which is why it’s so important to choose the right one. In this post, we’ll go over exactly what you should look for when making this decision. The way pharmaceutical labels are created is evolving, with AI-based […]
With the push towards Electronic Product Information (ePI) and the adoption of HL7 FHIR and Pharma Ledger standards, pharmaceutical companies face a crucial decision: When is it appropriate to to outsource ePI conversions to a professional service provider and when to to implement an in-house solution for long-term management? The choice is not a one-size-fits-all […]
